Carla Frederick is a Respiratory physician affiliated with University at Buffalo. OpenAlex indexes 22 publications with 611 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 High St
B8
Buffalo, NY 142031126
Telephone
716-859-2271Registry record last updated 21 Mar 2012.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Mylan Specialty L.P.Program year20241 payment
- Mylan Specialty L.P.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
61.2%beta2-Adrenergic Agonist25.4%Albuterol Sulfate Hfa89%Ventolin Hfa11%Part D<11 patientsCorticosteroid15.7%Symbicort35%Budesonide-Formoterol Fumarate25%Breo Ellipta18%Breztri Aerosphere11%Fluticasone Propionate11%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
27.6%Proton pump inhibitor12.2%Omeprazole57%Pantoprazole Sodium43%Part D<11 patientsCorticosteroid6.4%Prednisone100%Part D≥11 patients+ 3 more classes in this area
Anti-infectives
11.2%Macrolide Antimicrobial8.5%Azithromycin100%Part D≥11 patientsFluoroquinolone Antibacterial2.7%Levofloxacin100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO
The Journal of Clinical Endocrinology & Metabolism
2024 - Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI
Journal of Cystic Fibrosis
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Anne Curtis, MD
University at Buffalo
Paresh Dandona, MD
University at Buffalo
Gil Wolfe, MD
University at Buffalo
Uriel Halbreich, MD
University at Buffalo
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”